Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026)

Cabaletta Bio (CABA) posted quarterly Shares Outstanding (Entity) of $66.9 million for Q4 2025, up 495.89% year-over-year from $11.2 million in Q4 2024, and down 30.48% quarter-over-quarter from $96.3 million in Q3 2025.

Analysis

Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026) Analysis & Trends

Cabaletta Bio's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $66.9 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) rose 495.89% year-over-year to $66.9 million; the TTM figure through Dec 2025 stood at $66.9 million (up 495.89% YoY), while the FY2025 annual figure was $66.9 million, up 495.89% from the prior year.
  • Shares Outstanding (Entity) for Q4 2025 stood at $66.9 million, down from $96.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $96.3 million in Q3 2025, with the low at $507884.0 in Q2 2024.
  • The 5-year median for Shares Outstanding (Entity) is $10.5 million (2024), against an average of $22.5 million.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) tumbled 93.62% in 2023, then soared 12083.21% in 2025.
  • Cabaletta Bio's Shares Outstanding (Entity) stood at $4.3 million in 2021, then jumped by 41.25% to $6.0 million in 2022, then soared by 35.38% to $8.1 million in 2023, then jumped by 37.96% to $11.2 million in 2024, then surged by 495.89% to $66.9 million in 2025.
  • Business Quant data shows CABA's Shares Outstanding (Entity) at $66.9 million in Q4 2025, $96.3 million in Q3 2025, and $61.9 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Cabaletta Bio 522.26 Mn 522.26 Mn - 151.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 151.16 Mn
Dec 31, 2025 79.90 Mn
Sep 30, 2025 102.26 Mn
Jun 30, 2025 61.88 Mn
Mar 31, 2025 50.74 Mn
Dec 31, 2024 49.52 Mn
Sep 30, 2024 49.47 Mn
Jun 30, 2024 49.45 Mn
Mar 31, 2024 50.47 Mn
Dec 31, 2023 1.17 Mn
Sep 30, 2023 2.35 Mn
Jun 30, 2023 4.13 Mn
Mar 31, 2023 4.13 Mn
Dec 31, 2022 5.94 Mn
Sep 30, 2022 29.01 Mn
Jun 30, 2022 28.99 Mn
Mar 31, 2022 28.96 Mn
Dec 31, 2021 25.74 Mn
Sep 30, 2021 25.85 Mn
Jun 30, 2021 24.73 Mn